Search Results - "Mirimao, Federica"

Impaired Replication Timing Promotes Tissue-Specific Expression of Common Fragile Sites by Maccaroni, Klizia, Balzano, Elisa, Mirimao, Federica, Giunta, Simona, Pelliccia, Franca

“…Common fragile sites (CFSs) are particularly vulnerable regions of the genome that become visible as breaks, gaps, or constrictions on metaphase chromosomes…”
Get full text

Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations by Mannarino, Laura, Mirimao, Federica, Panini, Nicolò, Paracchini, Lara, Marchini, Sergio, Beltrame, Luca, Amodeo, Rosy, Grosso, Federica, Libener, Roberta, De Simone, Irene, Ceresoli, Giovanni L., Zucali, Paolo A., Lupi, Monica, D’Incalci, Maurizio

“…Although clinical antitumor activity of Tumor Treating Fields (TTFields) has been reported in malignant pleural mesothelioma (MPM) patients, the mechanisms…”
Get full text

Abstract 1064: Antiproliferative effects of Tumor Treating Fields in human mesothelioma cell lines by Lupi, Monica, Mirimao, Federica, Panini, Nicolò, Piazza, Greta, Paracchini, Lara, Mannarino, Laura, Marchini, Sergio, Grosso, Federica, Penpa, Serena, Maconi, Antonio, Ceresoli, Giovanni L., D'Incalci, Maurizio

“…Abstract Despite the increasing knowledge of the biology of malignant pleural mesothelioma (MPM), patients with this diagnosis still have a poor prognosis with…”
Get full text

Abstract LB-B13: Lurbinectedin down-regulates ASCL1 transcription factor in Small Cell Lung Cancer (SCLC) by Mannarino, Laura, Craparotta, Ilaria, Mirimao, Federica, Panini, Nicolò, Lupi, Monica, Protti, Giulia, Frapolli, Roberta, Marchini, Sergio, D'Incalci, Maurizio

“…Abstract The reported clinical activity of lurbinectedin in Small Cell Lung Cancer (SCLC) prompted us to investigate the selective mechanism of this drug in…”
Get full text

Abstract 7199: The retinoid X receptor (RXR) agonist IRX4204 potentiates the efficacy of trabectedin and pioglitazone in myxoid liposarcoma preclinical models by Meroni, Marina, Craparotta, Ilaria, Mirimao, Federica, Panini, Nicolò, Ubezio, Paolo, Bello, Ezia, Renne, Salvatore Lorenzo, D'Incalci, Maurizio, Frapolli, Roberta

“…Abstract Myxoid liposarcoma (MLS) is characterized by a chromosomal translocation that results in the formation of the FUS-DDTI3 fusion protein, which blocks…”
Get full text

Abstract 4883: Pan cancer transcriptomic response to tumor treating fields (TTFields) by Wainer-Katsir, Kerem, Lavy-Shahaf, Gitit, Fishman, Hila, Ena, Hila, Frechtel-Gerzi, Roni, Martinez-Conde, Antonia, Dor-On, Eyal, Davidi, Shiri, Jacobovitch, Sara, Tzchori, Itai, Porat, Yaara, Ding, Lianghao, Story, Michael, Du, Renfei, Kahlert, Ulf, Mannarino, Laura, Mirimao, Federica, Lupi, Monica, D’Incalci, Maurizio, Haber, Adi, Giladi, Moshe, Weinberg, Uri, Palti, Yoram

“…Abstract Introduction: Tumor Treating Fields (TTFields) are electric fields that disrupt cellular processes critical for cancer cell viability and tumor…”
Get full text